Galmed Pharmaceuticals
GLMD
#9871
Rank
HK$34.79 M
Marketcap
HK$23.09
Share price
-3.57%
Change (1 day)
-39.03%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2024 (TTM): -HK$46 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$53.74 Million, an increase over its 2022 earnings that were of -HK$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$46 Million-14.4%
2023 -HK$53.74 Million-61.31%
2022 -HK$0.14 Billion-44.97%
2021 -HK$0.26 Billion12.85%
2020 -HK$0.23 Billion40.61%
2019 -HK$0.16 Billion109.19%
2018 -HK$76.05 Million-20.47%
2017 -HK$95.62 Million-27%
2016 -HK$0.14 Billion58.6%
2015 -HK$82.59 Million16.7%
2014 -HK$70.77 Million-47.94%
2013 -HK$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$6.01 Billion 13,039.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$18.6 Billion 40,558.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-HK$0.19 Billion 295.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$46.86 Million 2.45%๐Ÿ‡บ๐Ÿ‡ธ USA